These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 813933)

  • 1. Detection of rubella-specific serum IgG and IgA and nasopharyngeal IgA responses using a radioactive single radial immunodiffusion technique.
    Al-Nakib W; Best JM; Banatvala JE
    Clin Exp Immunol; 1975 Nov; 22(2):293-301. PubMed ID: 813933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rubella-specific serum and nasopharygeal immunoglobulin responses following naturally acquired and vaccine-induced infection. Prolonged persistence of virus-specific IgM.
    Al-Nakib W; Best JM; Banatvala JE
    Lancet; 1975 Jan; 1(7900):182-5. PubMed ID: 47417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and persistence of class-specific antibodies in the serum and nasopharyngeal washings of rubella vaccinees.
    O'Shea S; Best JM; Banatvala JE; Shepherd WM
    J Infect Dis; 1985 Jan; 151(1):89-98. PubMed ID: 3965597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistence of rubella antibodies after vaccination: detection after experimental challenge.
    Banatvala JE; Best JM; O'Shea S; Dudgeon JA
    Rev Infect Dis; 1985; 7 Suppl 1():S86-90. PubMed ID: 4001741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific immunoglobulin responses in serum and nasal secretions after the administration of attenuated rubella vaccine.
    Cradock-Watson JE; Macdonald H; Ridehalgh MK; Bourne MS; Vandervelde EM
    J Hyg (Lond); 1974 Aug; 73(1):127-41. PubMed ID: 4608331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody response in serum and nasopharynx after naturally acquired and vaccine-induced infection with rubella virus.
    Ogra PL; Kerr-Grant D; Umana G; Dzierba J; Weintraub D
    N Engl J Med; 1971 Dec; 285(24):1333-9. PubMed ID: 4107718
    [No Abstract]   [Full Text] [Related]  

  • 7. Rubella-specific serum and nasopharyngeal antibodies in volunteers with naturally acquired and vaccine-induced immunity after intranasal challenge.
    Harcourt GC; Best JM; Banatvala JE
    J Infect Dis; 1980 Aug; 142(2):145-55. PubMed ID: 7410897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diagnosis of rubella by demonstrating rubella-specific 19 S and 7 S antibodies (author's transl)].
    Dibbert HJ
    Zentralbl Bakteriol Orig A; 1976 Mar; 234(2):145-58. PubMed ID: 1274496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rubella serology by solid-phase radioimmunoassay: its potential for screening programmes.
    Sugishita C; O'Shea S; Best JM; Banatvala JE
    Clin Exp Immunol; 1978 Jan; 31(1):50-4. PubMed ID: 639348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody titres in women six to eight years after the administration of RA2713 and Cendehill rubella vaccines.
    Macdonald H; Tobin JO; Cradock-Watson JE; Lomax J
    J Hyg (Lond); 1978 Jun; 80(3):337-47. PubMed ID: 649946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of immunoglobulin M-antibodies after rubella immunization with RA27/3 attenuated live vaccine in teen-agers: remaining problems.
    Braito A; Fanti O; Rossolini GM; Cellesi C
    Boll Ist Sieroter Milan; 1991-1992; 70(1-2):443-8. PubMed ID: 1670047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rubella in Orkney: seroepidemiology and vaccination.
    Moffat MA; Heywood SN; Laughton E; Gould JJ; Freestone DS
    J Hyg (Lond); 1977 Jun; 78(3):419-27. PubMed ID: 266542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Rubella vaccination with "Cendehill" and "RA 27/3". Reinfection of vaccinated and naturally immune persons compared with the infection rate of susceptible persons within a 3-resp. 5-year observation period (author's transl)].
    Thomssen R
    Zentralbl Bakteriol Orig A; 1976 Nov; 236(2-3):163-84. PubMed ID: 1015009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccination of seronegative high-risk populations with attenuated rubella vaccine.
    Lehtinen MO; Hakkarainen K; Leinikki PO; Lehtinen TK; Mattila LM; Helle EP
    Ann Clin Res; 1982 Dec; 14(5-6):213-9. PubMed ID: 7171230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for rubella antibodies by a single radial haemolysis test.
    Degré M; Rollag H
    NIPH Ann; 1979 Dec; 2(2):25-30. PubMed ID: 398458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Duration of circulating and secretory antibody and cell-mediated immunity following immunization.
    Waldman RH; Ganguly R
    Dev Biol Stand; 1975; 28():273-84. PubMed ID: 1126572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study of young women vaccinated against rubella virus for 10 years in Taiwan.
    Lin DB; Kao CL; Lee CY
    Southeast Asian J Trop Med Public Health; 1996 Dec; 27(4):707-14. PubMed ID: 9253871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Reasons for repeated serologically unsuccessful (HAI-HIG test) rubella vaccination (author's transl)].
    Ehrengut W; Florent G
    Dtsch Med Wochenschr; 1981 Jul; 106(31-32):987-9. PubMed ID: 7261921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Waning antibodies in measles and rubella vaccinees--a longitudinal study.
    Kremer JR; Schneider F; Muller CP
    Vaccine; 2006 Mar; 24(14):2594-601. PubMed ID: 16427163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IgG, IgA and IgM responses in acute rubella determined by the immunofluorescent technique.
    Cradock-Watson JE; Bourne MS; Vandervelde EM
    J Hyg (Lond); 1972 Sep; 70(3):473-85. PubMed ID: 4627265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.